TYPE 1 INTERFERONOPATHIES

Clinical trials for TYPE 1 INTERFERONOPATHIES explained in plain language.

Never miss a new study

Get alerted when new TYPE 1 INTERFERONOPATHIES trials appear

Sign up with your email to follow new studies for TYPE 1 INTERFERONOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First human test for new drug targeting devastating genetic immune diseases

Disease control Recruiting now

This is a very early study to check the safety of a new drug called IMSB301 in people with rare, lifelong genetic conditions known as type 1 interferonopathies. The study will enroll about 6 patients, aged 12 and up, who have specific genetic mutations. Researchers will give part…

Matched conditions: TYPE 1 INTERFERONOPATHIES

Phase: PHASE1 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

TYPE 1 INTERFERONOPATHIES

Get alerted when new TYPE 1 INTERFERONOPATHIES trials appear

First human test for new drug targeting devastating genetic immune diseases